Skip to main content

21 March 2005

Smiths Group today confirmed that it has completed the acquisition of Medex Inc, the US medical devices company. The consideration comprised $655million for the shares, satisfied in cash, and the assumption of net debt of $270million. The sellers were One Equity Partners, a division of JP Morgan Chase & Co, with 83% of the equity, and the management of Medex, who held the remainder. Completion followed the clearance by regulatory authorities in all countries where it was required.

Commenting on the acquisition, Keith Butler-Wheelhouse, Chief Executive of Smiths Group said:

Medex is a first rate company. It is an excellent strategic fit and we have secured it at a good price. This transaction is a significant step in the continuing evolution of Smiths, and moves us into the medical devices big league.

Medex will be integrated into Smiths Medical and the combined business will hold a strong position in the market for critical care devices used in healthcare systems around the world. Smiths Medical is a leading supplier of devices and equipment used in hospitals and other locations providing intensive and continuing care for patients.

ENDS

Related articles

Hypertac

Smiths Interconnect launches new technology to reduce power loss in industrial batteries

Innovative, environmentally friendly product provides up to 90% more energy transfer than existing offering

Find out more Call to action arrow icon
Alister Cowan

Smiths Group Appoints Alister Cowan as Non-Executive Director

Find out more Call to action arrow icon
Earth View

Smiths Group plc – Q3 Trading Update

Find out more Call to action arrow icon
Sign up for updates Call to action arrow icon